TY  - JOUR
AU  - Di Nardo, Lucia
AU  - Del Regno, Laura
AU  - Di Stefani, Alessandro
AU  - Mannino, Maria
AU  - Fossati, Barbara
AU  - Catapano, Silvia
AU  - Quattrini, Laura
AU  - Alpay, Yeliney
AU  - Pellegrini, Cristina
AU  - Cortellini, Alessio
AU  - Parisi, Alessandro
AU  - Capoluongo, Ettore
AU  - Autilio, Chiara
AU  - Fargnoli, Maria Concetta
AU  - Peris, Ketty
PY  - 2023
DO  - 10.1111/exd.14901
SN  - 0906-6705
UR  - https://hdl.handle.net/20.500.14352/121240
T2  - Experimental Dermatology
AB  - Despite the introduction of targeted (BRAFi/MEKi) and immune checkpoint inhibitors (ICIs) has significantly reduced the recurrence rate and improved the overall survival (OS) of patients with Stage III and IV melanoma, only a percentage will benefit...
LA  - eng
M2  - 1785
PB  - Wiley
KW  - Circulating tumour DNA
KW  - Follow-up studies
KW  - Immune checkpoint inhibitors
KW  - Melanoma
KW  - Progression-free survival
TI  - The dynamics of circulating tumour DNA (ctDNA) during treatment reflects tumour response in advanced melanoma patients
TY  - journal article
VL  - 32
ER  -